Letter to the editor

DOI: 10.4244/EIJ-D-23-00830

Letter: Due to the lack of significant mortality benefit along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged

Mohammad Reza Movahed1, MD, PhD

With great interest, I read the manuscript entitled “Three-year Outcomes of A Randomised Multicenter Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)” in EuroIntervention1. They confirmed numerous previous data that chronic total occlusion (CTO) interventions do not improve clinically significant outcomes, myocardial infarction or mortality. However, the authors overstated the benefit of a CTO intervention by stating that CTO percutaneous coronary intervention (PCI) appears to be a safe option for patients with a single remaining significant coronary CTO. The authors completely downplayed numerous trials showing very high complication rates in patients undergoing CTO PCI in comparison to other lesions23. We recently published the largest data regarding CTO PCI confirming much higher in-patient mortality and complications in this population4. A weighted total of 259,574 patients underwent CTO PCI. The CTO patients had a 3.17% mortality rate versus 2.57% for non-CTO PCIs (odds ratio [OR] 1.24), which remained significant despite adjusting for numerous baseline and clinical characteristics. Furthermore, patients with CTO were compared with non-CTO PCI, showing much higher rates of myocardial infarction...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 1
Jan 1, 2024
Volume 20 Number 1
View full issue

Key metrics

On the same subject


10.4244/EIJ-E-23-00040 Sep 18, 2023
Reconsidering the evidence for CTO PCI: the devil is in the detail
Al-Lamee R et al

10.4244/EIJV12I11A218 Dec 9, 2016
Conquering CTO revascularisation: the summit is near with 90% of the ascent behind us
Di Mario C and Dini C

Research correspondence

10.4244/EIJ-D-22-00599 Dec 2, 2022
In-hospital outcomes and temporal trends of percutaneous coronary interventions for chronic total occlusion
Kostantinis S et al

Clinical research

10.4244/EIJ-D-19-00441 Dec 4, 2020
Technical and procedural outcomes of the retrograde approach to chronic total occlusion interventions
Tajti P et al
Trending articles

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al


10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al


10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved